ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
4,325
Screening encounters
5,410
Diagnostic referrals
1,028
Outstanding pathways
306

Screening pathway

  1. Screening5,410Encounters
  2. Positive finding1,897Documented findings
  3. Referral1,028Diagnostic referrals
  4. Follow-up1,283Diagnostic visits
  5. Outcome722Resolved pathways

Stage totals use different units. Pending pathways: 306. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0655 · EXP-0655Synthetic · Site C

Full participant history through 2027-06-10, across modalities and pathways.

  1. · Screening · Cytology · Initial · Programme entry
  2. · Screening result · Cytology · LSIL · Adequate
  3. · Diagnostic referral · EXP-0655-T-R
  4. · Contact attempt · Unsuccessful
  5. · Barrier documented · Appointment coordination
  6. · Diagnostic booking · Initial booking
  7. · Contact attempt · Reached
  8. · Barrier documented · Contact difficulty
  9. · Diagnostic visit · Attended
  10. · Diagnosis · Colposcopy · Biopsy collected
  11. · Diagnosis · Histopathology · No high-grade lesion identified
  12. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2028-03-27
  13. · Follow-up disposition · Resolved · EXP-0655-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Unresolved

Screened participants

4325 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0569 · Expanded synthetic participant 0569Site D — Community Engagement Programme
EXP-0571 · Expanded synthetic participant 0571Site E — Resource-Constrained Navigation Programme
EXP-0572 · Expanded synthetic participant 0572Site A — Urban Referral Hub
EXP-0573 · Expanded synthetic participant 0573Site C — Rural Outreach Programme
EXP-0574 · Expanded synthetic participant 0574Site A — Urban Referral Hub
EXP-0575 · Expanded synthetic participant 0575Site C — Rural Outreach Programme
EXP-0576 · Expanded synthetic participant 0576Site A — Urban Referral Hub
EXP-0577 · Expanded synthetic participant 0577Site D — Community Engagement Programme
EXP-0578 · Expanded synthetic participant 0578Site E — Resource-Constrained Navigation Programme
EXP-0580 · Expanded synthetic participant 0580Site D — Community Engagement Programme
EXP-0581 · Expanded synthetic participant 0581Site B — Peri-Urban Access Programme
EXP-0582 · Expanded synthetic participant 0582Site E — Resource-Constrained Navigation Programme
EXP-0583 · Expanded synthetic participant 0583Site A — Urban Referral Hub
EXP-0584 · Expanded synthetic participant 0584Site C — Rural Outreach Programme
EXP-0585 · Expanded synthetic participant 0585Site B — Peri-Urban Access Programme
EXP-0586 · Expanded synthetic participant 0586Site A — Urban Referral Hub
EXP-0587 · Expanded synthetic participant 0587Site A — Urban Referral Hub
EXP-0588 · Expanded synthetic participant 0588Site D — Community Engagement Programme
EXP-0589 · Expanded synthetic participant 0589Site E — Resource-Constrained Navigation Programme
EXP-0590 · Expanded synthetic participant 0590Site D — Community Engagement Programme
EXP-0591 · Expanded synthetic participant 0591Site B — Peri-Urban Access Programme
EXP-0592 · Expanded synthetic participant 0592Site A — Urban Referral Hub
EXP-0594 · Expanded synthetic participant 0594Site C — Rural Outreach Programme
EXP-0597 · Expanded synthetic participant 0597Site C — Rural Outreach Programme
EXP-0599 · Expanded synthetic participant 0599Site C — Rural Outreach Programme

Programme insights

Encounters by modality

VIA
1968
HPV DNA
2715
Cytology
727

Navigation activity

Barrier documented
930
Contact attempt
1497
Navigation intervention
417
Diagnostic booking
1298
Diagnostic visit
1283

Documented barriers

Contact difficulty
297
Transport difficulty
308
Appointment coordination
325

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.